The shot made by Gilead Sciences nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take.
A twice-yearly shot of this drug could help end AIDS — ‘it’s unprecedented’
BY MARIA CHENG, MARÍA VERZA AND OTHERS
December 2, 2024
A precarious success story: In South Africa, the hard-won progress of a youth-led HIV education program is threatened by international funding cuts
June 3, 2025
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
US approves Gilead’s twice-yearly shot for HIV prevention
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
FDA approves new twice-yearly HIV shot. What to know
FDA approves long-lasting HIV-prevention drug - UPI.com
Rivoluzione Hiv: la Fda approva le due iniezioni l’anno per prevenire l’infezione
Fda Usa approva un nuovo farmaco per prevenire l'Aids - Sanità - Ansa.it
Les Etats-Unis approuvent un traitement préventif très prometteur contre le VIH, évoquant « un jour historique » dans la lutte contre le sida
South Africa is at the heart of the HIV pandemic. What happens now the money has been cut?
Regulators Approve Lenacapavir for H.I.V. Prevention
